Skip Nav Destination
Leiden University Medical Centre
Leiden, Netherlands
Dr. Willem E. Fibbe is Emeritus Professor of Hematology and Stem Cell Biology at Leiden University Medical Centre (LUMC) in the Netherlands. He completed his PhD in 1988 (cum laude) on "Interleukin-1 , a regulator of hematopoiesis" and later became Head of Bone Marrow Transplantation and the Department of Immunohematology. He has held various leadership roles at LUMC, was president of the European Hematology Association (EHA) and served on committees for the EMA, WHO, ISEH, NetCord and ASH. He is an active member of the Netherlands Clinical Trial Competent Authority. Dr. Fibbe's research focuses on hematopoietic stem cell biology, regenerative medicine, and cellular therapies. He co-founded the Leiden Regenerative Medicine Platform and is CSO of Starfish Innovations. In 2018, he was named Knight in the Order of the Lion of the Netherlands.
Editorial Board
Inaugural Editor-in-Chief
Willem Fibbe, MD, PhDLeiden University Medical Centre
Leiden, Netherlands
Dr. Willem E. Fibbe is Emeritus Professor of Hematology and Stem Cell Biology at Leiden University Medical Centre (LUMC) in the Netherlands. He completed his PhD in 1988 (cum laude) on "Interleukin-1 , a regulator of hematopoiesis" and later became Head of Bone Marrow Transplantation and the Department of Immunohematology. He has held various leadership roles at LUMC, was president of the European Hematology Association (EHA) and served on committees for the EMA, WHO, ISEH, NetCord and ASH. He is an active member of the Netherlands Clinical Trial Competent Authority. Dr. Fibbe's research focuses on hematopoietic stem cell biology, regenerative medicine, and cellular therapies. He co-founded the Leiden Regenerative Medicine Platform and is CSO of Starfish Innovations. In 2018, he was named Knight in the Order of the Lion of the Netherlands.
Advertisement intended for health care professionals
